Search Results - "Boer‐Martins, Leandro"

Serelaxin in addition to standard therapy in acute heart failure: rationale and design of the RELAX‐AHF‐2 study by Teerlink, John R., Voors, Adriaan A., Ponikowski, Piotr, Pang, Peter S., Greenberg, Barry H., Filippatos, Gerasimos, Felker, G. Michael, Davison, Beth A., Cotter, Gad, Gimpelewicz, Claudio, Boer‐Martins, Leandro, Wernsing, Margaret, Hua, Tsushung A., Severin, Thomas, Metra, Marco

“…Patients admitted for acute heart failure (AHF) experience high rates of in‐hospital and post‐discharge morbidity and mortality despite current therapies…”
Get full text

Day vs. Night: Does time of presentation matter in Acute Heart Failure? A secondary analysis from the RELAX-AHF Trial by Pang, Peter S, Teerlink, John R, Boer-Martins, Leandro, Gimpelewicz, Claudio, Davison, Beth A, Wang, Yi, Voors, Adriaan A, Severin, Thomas, Ponikowski, Piotr, Hua, Tsushung A, Greenberg, Barry H, Filippatos, Gerasimos, Felker, G. Michael, Cotter, Gad, Metra, Marco

“…Background Signs and symptoms of heart failure can occur at any time. Differences between acute heart failure (AHF) patients who present at nighttime vs…”
Get full text

Effects of Serelaxin on the Outcome of Patients with or without Substantial Peripheral edema: A Subgroup Analysis from the RELAX-AHF Trial by Gimpelewicz, Claudio, MD, Metra, Marco, MD, Cleland, John G.F, MD, PhD, Szecsödy, Peter, MD, Chang Wun, Chuan-Chuan, PhD, Boer- Martins, Leandro, MD, PhD, Cotter, Gad, MD, Davison, Beth A., PhD, Felker, G. Michael, MD, MHS, Filippatos, Gerasimos, MD, Greenberg, Barry H., MD, Pang, Peter, MD, MS, Ponikowski, Piotr, MD, PhD, Severin, Thomas, MD, Voors, Adrian A, MD, Teerlink, John R., MD

“…Background Acute heart failure (AHF) is a heterogeneous disorder with most of the patients presenting with breathlessness along with varying degrees of…”
Get full text

Hypoadiponectinemia and aldosterone excess are associated with lack of blood pressure control in subjects with resistant hypertension by de Faria, Ana P C, Demacq, Caroline, Figueiredo, Valéria N, Moraes, Carolina H, Santos, Rodrigo C, Sabbatini, Andréa R, Barbaro, Natália R, Boer-Martins, Leandro, Fontana, Vanessa, Moreno, Jr, Heitor

“…Obesity, arterial stiffness and high aldosterone levels can interact to cause resistant hypertension (RHTN). Lower adiponectin (APN) levels may be…”
Get full text

Relationship of autonomic imbalance and circadian disruption with obesity and type 2 diabetes in resistant hypertensive patients by Boer-Martins, Leandro, Figueiredo, Valéria N, Demacq, Caroline, Martins, Luiz C, Consolin-Colombo, Fernanda, Figueiredo, Márcio J, Cannavan, Fernando P S, Moreno, Jr, Heitor

“…Hypertension, diabetes and obesity are not isolated findings, but a series of interacting interactive physiologic derangements. Taking into account genetic…”
Get full text

Leptina e aldosterona na atividade simpática na hipertensão resistente, com ou sem Diabetes Tipo 2 by Boer-Martins, Leandro, Figueiredo, Valéria Nasser, Demacq, Caroline, Martins, Luiz Cláudio, Faria, Ana Paula Cabral de, Moraes, Carolina de Haro, Moreno Jr, Heitor

“…FUNDAMENTO: A descoberta da leptina como um estimulador da atividade simpática trouxe uma nova perspectiva para os mecanismos fisiopatológicos da…”
Get full text

Vascular stiffness and endothelial dysfunction: Correlations at different levels of blood pressure by Figueiredo, Valéria Nasser, Yugar-Toledo, Juan Carlos, Martins, Luiz Cláudio, Martins, Leandro Boer, de Faria, Ana Paula Cabral, de Haro Moraes, Carolina, Sierra, Cristina, Coca, Antonio, Moreno, Heitor

“…Resistant hypertensive (RHTN) patients have endothelial dysfunction and aldosterone excess, which contribute to the development of resistance to…”
Get more information

The white coat effect is not associated with additional increase of target organ damage in true resistant hypertension by Figueiredo, Valéria Nasser, Martins, Luiz Cláudio, Boer-Martins, Leandro, Cabral de Faria, Ana Paula, de Haro Moraes, Carolina, Cardoso Santos, Rodrigo, Nogueira, Armando R, Moreno, Jr, Heitor

“…White coat effect (WCE) (i.e., the difference between office blood pressure [OBP] and awake ambulatory blood pressure monitoring [ABPM]) may be present in…”
Get more information

Leptina e aldosterona na atividade simpática na hipertensão resistente, com ou sem Diabetes Tipo 2 Leptin and aldosterone in sympathetic activity in resistant hypertension with or without type 2 diabetes by Leandro Boer-Martins, Valéria Nasser Figueiredo, Caroline Demacq, Luiz Cláudio Martins, Ana Paula Cabral de Faria, Carolina de Haro Moraes, Heitor Moreno Jr

“…FUNDAMENTO: A descoberta da leptina como um estimulador da atividade simpática trouxe uma nova perspectiva para os mecanismos fisiopatológicos da…”
Get full text

Leptina e aldosterona na atividade simpática na hipertensão resistente, com ou sem Diabetes Tipo 2 by Boer-Martins, Leandro, Figueiredo, Valéria Nasser, Demacq, Caroline, Martins, Luiz Cláudio, Faria, Ana Paula Cabral de, Moraes, Carolina de Haro, Moreno Jr, Heitor

Get full text

Leptin and aldosterone in sympathetic activity in resistant hypertension with or without type 2 diabetes by Boer-Martins, Leandro, Figueiredo, Valéria Nasser, Demacq, Caroline, Martins, Luiz Cláudio, Faria, Ana Paula Cabral de, Moraes, Carolina de Haro, Moreno, Jr, Heitor

“…The finding of adipocyte-derived hormone leptin as an overstimulator of sympathetic activity brought a new perspective to the pathophysiological mechanisms of…”
Get full text

Infliximab reduces cardiac output in rheumatoid arthritis patients without heart failure by Cardoso Santos, Rodrigo, Nasser Figueiredo, Valéria, Cláudio Martins, Luiz, Haro Moraes, Carolina de, Quinaglia, Thiago, Boer-Martins, Leandro, Ferreira-Melo, Sílvia Elaine, Alexandre Yazbek, Michel, Bertolo, Manoel, Moreno Junior, Heitor

Get full text

Infliximab reduces cardiac output in rheumatoid arthritis patients without heart failure by Cardoso Santos, Rodrigo, Nasser Figueiredo, Valéria, Cláudio Martins, Luiz, Haro Moraes, Carolina de, Quinaglia, Thiago, Boer-Martins, Leandro, Ferreira-Melo, Sílvia Elaine, Alexandre Yazbek, Michel, Bertolo, Manoel, Moreno Junior, Heitor

“…Human anti-tumor necrosis factor (TNF-α) monoclonal antibody (infliximab) is used to treat autoimmune diseases such as rheumatoid arthritis (RA). Although the…”
Get full text